• Stories
    • See all Stories >

    • The Influence of Inflammation on Mental HealthRead More

    • Machine learning and infectious disease: how we can better understand vaccine efficacy at the patient levelRead More

    • The intestinal stem cell response Investigating transcriptomic changes at the microscale levelRead More

    • DNA Fingerprinting at a Genetics BiorepositoryRead More

Consumables

Anti-Human NKB1 (DX9)-167Er—100 Tests

The DX9 monoclonal antibody specifically binds to CD158e1, also known as NKB1. CD158e1 is a 70 kDa member of the immunoglobulin superfamily that is expressed on a subset of natural killer cells and T cells. CD158e1 functions as a killer cell inhibitory receptor (KIR) and is encoded by KIR3DL1 (killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail). Interaction of CD158e1 with specific HLA-B antigen on a target cell has been reported to inhibit cell-mediated cytotoxicity by delivering a negative signal that limits lymphocyte activation. It is suggested that this MHC class I-KIR interaction acts to regulate NK and T cell responses to antigenic challenge.

  • Species:
    Human
  • Clone:
    DX9
  • Target:
    CD158e1/KIR3DL1, NKB1
  • Tag:
    167Er
 

Browse more products